DMK Pharmaceuticals Corporation
DMKPQ · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $3 | $9 | $4 | $4 |
| - Cash | $1 | $23 | $7 | $9 |
| + Debt | $0 | $1 | $4 | $4 |
| Enterprise Value | $2 | -$14 | $1 | -$1 |
| Revenue | $5 | $2 | $3 | $22 |
| % Growth | 115.3% | -20.5% | -87.4% | – |
| Gross Profit | -$3 | -$5 | -$4 | $6 |
| % Margin | -60.9% | -211.1% | -127.9% | 29.1% |
| EBITDA | -$24 | -$31 | -$34 | -$25 |
| % Margin | -495.7% | -1,387% | -1,206.7% | -113.4% |
| Net Income | -$26 | -$46 | -$49 | -$28 |
| % Margin | -556.7% | -2,074.9% | -1,778.8% | -124.4% |
| EPS Diluted | -12.37 | -22.25 | -44.57 | -36.16 |
| % Growth | 44.4% | 50.1% | -23.3% | – |
| Operating Cash Flow | -$26 | -$38 | -$21 | -$20 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$3 |
| Free Cash Flow | -$27 | -$39 | -$22 | -$23 |